Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells.

Auteurs : Al Akoum C, Akl I, Rouas R, Fayyad-Kazan M, Falha L, Renno T, Burny A, Lewalle P, Fayyad-Kazan H, Badran B
Jaar : 2015
Journal : Hum Immunol
Volume : 76(5)
Pagina's : 307-17

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

Auteurs : Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H, Vaes M, Bron D
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42(8)
Pagina's : 1304-14

In honor of Professor Philippe Martiat

Auteurs : Bron D, Lewalle P
Jaar : 2015
Journal : Rev Med Brux
Volume : 36(1)
Pagina's : 58-9

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Auteurs : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Mol. Med.
Volume : 21(1)
Pagina's : 123-33

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.

Auteurs : Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N
Jaar : 2015
Journal : Ann Hematol
Volume : 94(4)
Pagina's : 633-41

In vivo characterizatio of the BLV miRNA cluster

Auteurs : Rodari A, Van Driessche B, Delacourt N, Vanhulle C, Burny A, Van den Broeke A, Rohr O, Van Lint C
Jaar : 2015
Journal : Retrovirology
Volume : 12(1
Pagina's : 11

Circadian and circannual variations in cord blood hematopoietic cell composition.

Auteurs : Servais S, Baudoux E, Brichard B, Bron D, Debruyn C, De Hemptinne D, Deneys V, Paulus JM, Schaaps JP, Van Cauwenberge JR, Seidel L, Delforge A, Beguin Y
Jaar : 2015
Journal : Haematologica
Volume : 100(1)
Pagina's : 32-34

Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2015
Journal : Stem Cell Rev
Volume : 11(3)
Pagina's : 442-52

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24

Myelofibrosis patients in Belgium: disease characteristics.

Auteurs : Devos T, Zachée P, Bron D, Noens L, Droogenbroeck JV, Mineur P, Beguin Y, Berneman Z, Benghiat FS, Kentos A, Chatelain C, Demuynck H, Lemmens J, Eygen KV, Theunissen K, Trullemans F, Pierre P, Pluymers W, Knoops L
Jaar : 2015
Journal : Acta Clin Belg
Volume : 70(2)
Pagina's : 105-11

Current management of marginal zone lymphomas.

Auteurs : Bonnet C, Lejeune M, Van Kemseke C, Bron D, Beguin Y
Jaar : 2015
Journal : Rev Med Suisse
Volume : 11
Pagina's : 1549-56

Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).

Auteurs : de Witte T, Suciu S, Meert L, Halkes C, Selleslag D, Bron D, Amadori S, Willemze R, Muus P, Baron F
Jaar : 2015
Journal : Ann Hematol
Volume : 94
Pagina's : 1981-9

Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].

Auteurs : Bron D, de Wind R, Cantinieaux B, Woff E, Roelandts M, Moerman C, Lemort M, Heimann P, de Wilde V, Meuleman N, Maerevoet M
Jaar : 2015
Journal : Rev Med Brux
Volume : 36
Pagina's : 237-47

The prevalence and implications of elderly inpatients' desire for a formal psychological help at the start of cancer treatment.

Auteurs : Dubruille S, Libert Y, Merckaert I, Reynaert C, Vandenbossche S, Roos M, Bron D, Razavi D
Jaar : 2015
Journal : Psychooncology
Volume : 24(3)
Pagina's : 294-301

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Auteurs : Rondeau V, Pignon JP, Michiels S
Jaar : 2015
Journal : Stat Methods Med Res
Volume : 24
Pagina's : 711-29

Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.

Auteurs : Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, Bron D
Jaar : 2015
Journal : J Geriatr Oncol
Volume : 24(3)
Pagina's : 294-301

Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicentre prospective study.

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2015
Journal : J Geriatr Oncol
Volume : 6(5)
Pagina's : 401-10

Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-? secreted by activated human CD4 lymphocytes.

Auteurs : Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, Eldirani R, Hussein N, Fakhry M, Al-Akoum C, Burny A, Martiat P, Badran B
Jaar : 2014
Journal : Hum Immunol
Volume : 75(7)
Pagina's : 677-85

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Auteurs : Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, + collaborators (among others :, Ravoet C
Jaar : 2014
Journal : Leuk. Res.
Volume : 38(5)
Pagina's : 557-63

Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

Auteurs : Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Desmedt C, Piccart-Gebhart M, Loibl S, Denkert C, Smyth MJ, Joensuu H, Sotiriou C
Jaar : 2014
Journal : Ann Oncol
Volume : 25(8)
Pagina's : 1544-50